Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;202(3):551-561.
doi: 10.1007/s10549-023-07089-6. Epub 2023 Sep 14.

Long-term locoregional recurrence in patients treated for breast cancer

Affiliations

Long-term locoregional recurrence in patients treated for breast cancer

Beatriz Costeira et al. Breast Cancer Res Treat. 2023 Dec.

Abstract

Background/purpose: Locoregional control in breast cancer is a fundamental part of treatment and determinant for survival outcomes. It has been reported that most locoregional recurrence (LRR) events occur in the first 5 years after treatment. However, LRR continue to occur after this timeline, with unclear risk factors and unknown survival impact.

Methods: Retrospective singe-centered cohort of patients treated for primary breast cancer, between January 2002 and December 2004. Primary outcome was LRR; secondary outcomes were overall survival (OS), disease-free survival (DFS), and predictive factors for LRR.

Results: This analysis included 1001 patients, of which 959 (95%) had invasive carcinoma. A mastectomy was performed in 501 (50%) and 500 (50%) had breast conservative surgery (BCS). Median follow-up time was 197 [Inter-quartile range (IQR) 96-211] months. Global LRR rate was 7.6%, with median time to recurrence of 45 [IQR 21-91] months. There was no difference in LRR rate after mastectomy vs BCS, adjusted to tumor stage (p > 0.05). The 10-year OS and DFS rates were 68.4 and 77.8%, respectively. Factors associated with LRR were metastatic axillary lymph nodes and high histologic grade (p < 0.05). Estrogen-negative (ER) tumors had higher LRR rates than ER-positive tumors in the first 5 years (p < 0.05); but no difference was observed with longer follow-up (p > 0.05). LRR was associated with OS (p < 0.05).

Discussion and conclusions: Global LRR in this cohort was 7.6% (with over 16 years of follow-up). LRR associates with decreased OS. Time to LRR varies significantly with tumor biology, supporting differentiation of follow-up regimens.

Keywords: Breast neoplasm; Breast-conserving surgery; Local neoplasm recurrence; Mastectomy; Survival Analysis.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
    1. Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO (2009) Open access improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 11:44. https://doi.org/10.1186/bcr2331 - DOI
    1. Berry DA, Cronin KA, Plevritis SK, et al. ( 2005) Effect of screening and adjuvant therapy on mortality from breast cancer for the cancer intervention and surveillance modeling network (CISNET) Collaborators, vol 17. http://cisnet.cancer.gov/
    1. Elmore JG, Reisch LM, Barton MB et al (2005) Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97(14):1035–1043. https://doi.org/10.1093/jnci/dji183 - DOI - PubMed
    1. Abe O, Abe R, Enomoto K et al (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717. https://doi.org/10.1016/S0140-6736(05)66544-0 - DOI

LinkOut - more resources